Antitumor protein hybrid and process for the preparation thereof
AssigneesTeijin Limited, Hidematsu Hirai
InventorsYasuhiko Masuho, Naoji Umemoto, Takeshi Hara, Hidematsu Hirai
Life of this patent
Estimating the term…
Loading patent…
AssigneesTeijin Limited, Hidematsu Hirai
InventorsYasuhiko Masuho, Naoji Umemoto, Takeshi Hara, Hidematsu Hirai
Estimating the term…
Antitumor protein hybrid, composed of a moiety which is substantially the fragment Fab of an anti-.alpha.-fetoprotein antibody and a moiety which is substantially the fragment A of a diphtheria toxin, which is expressed by the following formula (I): Fab--(S.sub.1 --(X).sub.n --S.sub.2 --FA).sub.m (I) (where Fab indicates a moiety which is substantially the fragment Fab of an anti-.alpha.-fetoprotein antibody; FA indicates a moiety which is substantially the fragment A of diphtheria toxin; X indicates a divalent organic radical; S.sub.1 and S.sub.2 are both sulfur atoms, S.sub.1 indicating a sulfur atom arising from the disulfide bond (--S--S--bond) in an anti-.alpha.-fetoprotein antibody and S.sub.2 a sulfur atom arising from the disulfide bond in a diphtheria toxin; n stands for 0 or 1 and m stands for an integer of 1 to 5). This antitumor protein hybrid has remarkable and specific citotoxicity against tumor cells.
Antitumor protein hybrid comprising (1) a moiety which is substantially the fragment Fab of an anti-.alpha.-fetoprotein antibody and (2) a moiety which is substantially the fragment A of a diphtheria toxin, which antitumor protein hybrid is expressed by the following formula (I):
Dependencies are inferred from the claim text.